Testing new treatments for Treponema pallidum infection in rabbits.
Task A95: Minimal Inhibitory Concentration (MIC) Testing and Efficacy Studies in a Rabbit Model of Treponema Pallidum Infection
This study is looking at how to better treat syphilis by testing new treatments on rabbits, which could help improve options for people dealing with this infection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tufts University Boston NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11197722 on NIH RePORTER |
What this research studies
This research focuses on developing and refining models to study Treponema pallidum infections, which cause syphilis. By using rabbits as a model organism, the research aims to evaluate the effectiveness of potential therapeutic agents against this infection. Patients may benefit from the insights gained through this research, as it could lead to improved treatment options for syphilis and related conditions. The methodology involves minimal inhibitory concentration (MIC) testing to determine the effectiveness of various treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by Treponema pallidum infections or those at risk of contracting syphilis.
Not a fit: Patients with other types of infections or those not affected by Treponema pallidum will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for syphilis and improve patient outcomes.
How similar studies have performed: Similar research has shown promise in using animal models to evaluate treatments for infectious diseases, indicating a potential for success in this approach.
Where this research is happening
Boston, United States
- Tufts University Boston — Boston, United States (Active)
Researchers
- Principal investigator: Tzipori, Saul — Tufts University Boston
- Study coordinator: Tzipori, Saul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.